New Massachusetts legislation bans the sale of menthol products; a group of hospitals is suing HHS; the FDA has approved a new treatment for partial-onset seizures.
A bill passed by Massachusetts lawmakers would ban sales of flavored tobacco and vaping products, including menthol cigarettes, according to the Associated Press, as well as impose a 75% excise tax on vaping products and require insurers to cover counseling for tobacco cessation. It was in September that Governor Charlie Baker first introduced a temporary 4-month ban, although he has not yet indicated whether he will sign the new bill. If it goes into law on June 1, 2020, it would be the first law of its kind in the nation.
Thirteen hospitals and Capital Health System have filed a lawsuit in the US District Court for the District of Columbia against HHS and HHS Secretary Alex Azar, according to Bloomberg Law. The hospitals claim they were not correctly reimbursed for services provided to low-income patients after a 2014 change in the calculation of such payments. They seek a declaration that the HHS decision is invalid and an order of new recalculation and repayment, along with attorneys’ fees and costs.
Based on findings from 2 studies, yesterday the FDA approved cenobamate (Xcopri), a new antiepileptic drug from SK Life Science that treats partial-onset seizures in adults. The drug has a maximum recommended dose of 400 mg when necessary, but in most cases, the dose will be 200 mg daily. Possible adverse effects include changes in mood or behavior, sleepiness, and headaches.
Personalized Care Key as Tirzepatide Use Expands Rapidly
April 15th 2025Using commercial insurance claims data and the US launch of tirzepatide as their dividing point, John Ostrominski, MD, Harvard Medical School, and his team studied trends in the use of both glucose-lowering and weight-lowering medications, comparing outcomes between adults with and without type 2 diabetes.
Listen
"The Barriers Are Real": Antoine Keller, MD, on Geography and Cardiovascular Health
April 18th 2025Health care disparities are often driven by where patients live, explained Antoine Keller, MD, as he discussed the complex, systematic hurdles that influence the health of rural communities.
Read More
Understanding How Fitness Affects Digestive Diseases
April 18th 2025Exercise is a powerful modulator of gut health in patients with gastrointestinal (GI) conditions, as moderate activity can ease gut inflammation, reduce colorectal cancer risk, and relieve constipation, while intense workouts may backfire, causing reflux, GI bleeding, or gut barrier disruption.
Read More
FDA Greenlights Dupilumab for Chronic Spontaneous Urticaria, Marking First Approval in a Decade
April 18th 2025Marking the first approval in over a decade for this challenging condition, the FDA has approved dupilumab (Dupixent) to treat chronic spontaneous urticaria in patients 12 years and older whose hives and itching remain uncontrolled by antihistamines.
Read More